Clinical trial
Analysis of Blood Samples in Small Cell Lung Cancer Patients Treated With Tarlatamab
NCT07468656 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Blood Samples in Small Cell Lung Cancer Patients Treated With Tarlatamab
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- December 31, 2028
- Enrollment
- 25 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
small-cell lung cancer